midecamycin   Click here for help

GtoPdb Ligand ID: 13158

Synonyms: espinomycin A | platenomycin B1 | rubimycin | SF-837 | turimycin P3
Approved drug
midecamycin is an approved drug
Compound class: Natural product
Comment: Midecamycin is a 16-membered macrolide antibacterial, originally isolated from culture broth of Streptomyces mycarofaciens [1-2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 16
Hydrogen bond donors 3
Rotatable bonds 14
Topological polar surface area 206.05
Molecular weight 813.97
XLogP 2.13
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@@H]([C@H](C)C[C@H](CC=O)[C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](C)O2)O[C@H]3C[C@](C)([C@H]([C@H](C)O3)OC(=O)CC)O)N(C)C)O)O
Isomeric SMILES CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C
InChI InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1
InChI Key DMUAPQTXSSNEDD-QALJCMCCSA-N
No information available.
Summary of Clinical Use Click here for help
Midecamycin was first marketed in Japan in 1974 by Meiji Seika Pharma and used as an oral treatment for a wide range of infections caused by susceptible bacteria. There is no information regarding current approval for clinical use of this drug on the US FDA or European Medicines Agency (EMA) websites. However, midecamycin does have marketing authorisation in a number of jurisdictions, including Bulgaria and Slovenia.